Skip to content

Research library / Observational study

Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes

Brown TK, Alper K. American Journal of Drug and Alcohol Abuse 2018;44(1):24-36

Observational studyIbogaineopioid use disorder

This study followed 30 people with opioid dependence, mostly men using oxycodone or heroin who had already tried treatment about three times on average, through detoxification with ibogaine, a psychoactive plant alkaloid. Withdrawal symptoms roughly halved within about three days of treatment. One month later, half said they had not used opioids in the previous 30 days. Scores for drug use, legal problems and family and social life stayed better than before treatment over the following year, though the drug use benefit was largest at one month and partly faded. With no comparison group and self-reported drug use, the study cannot show ibogaine caused the improvements.

What it found

  • Withdrawal scores (SOWS) fell from 31.0 before treatment to 14.0 about 76 hours after
  • 15 of 30 (50%) reported no opioid use in the 30 days before the 1-month follow-up
  • Drug use, legal and family/social scores improved at all follow-ups to 12 months; drug use gains peaked at 1 month
Read the paper

The dispatch

Laws change. Centres change. Know before you book.

A brief, sent only in weeks when something changes: jurisdictions that shifted, listings added or revised, and the research worth reading. No hype, no sourcing talk.

Educational only. Not medical advice. Unsubscribe any time.